Citation Impact
Citing Papers
International Union of Pharmacology nomenclature of adrenoceptors.
1994 StandoutNobel
Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α‐ and β‐subtypes
1988
Catecholamine Receptors: Structure, Function, and Regulation
1993 StandoutNobel
Descending control of pain
2002 Standout
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices
1993
Interactions of Dopaminergic and Peptidergic Factors in the Control of Prolactin Release*
1990
Alpha‐adrenoceptors: A critical review
1989
Hypotensive and Vasorelaxing Activities of a Lectin from the Edible Mushroom Tricholoma mongolicum
1996
Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture
1992
Specific binding of 125I SCH 23982, a selective dopamine (D1) receptor ligand to plasma membranes derived from human kidney cortex
1989
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393
1987 StandoutNobel
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
Dopaminergic defect in hypertension
1993
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists
1990 StandoutNobel
EFFECT OF APOMORPHINE ON ADRENAL MEDULLARY CATECHOLAMINE LEVELS
1989
Acute dopaminergic influence on plasma adrenaline levels in the rat
1995 StandoutNobel
Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice
1992 StandoutNobel
5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods
2002 Standout
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
1987
Dopamine Receptors on Adrenal Chromaffin Cells Modulate Calcium Uptake and Catecholamine Release
1988
Angiotensin II Receptor Antagonists: An Emerging New Class of Cardiovascular Therapeutics.
1999
Dopamine receptor subtypes: beyond the D1/D2 classification
1990
Differential Regulation of Dopamine D1A Receptor Responsiveness by Various G Protein-coupled Receptor Kinases
1996 StandoutNobel
In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390
1988 StandoutNobel
Two dopamine receptors: Biochemistry, physiology and pharmacology
1984
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats
1986 StandoutNobel
The physiological and pharmacological role of presynaptic alpha‐ and beta‐adrenoceptors in man.
1985
A response to isoprenaline unrelated to α‐and β‐adrenoceptor agonism
1987
Basic mechanisms and local modulation of nerve impulse-induced secretion of neurotransmitters from individual sympathetic nerve varicosities
2005
Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy
1996
Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity
2006 Standout
The renal dopamine receptors.
1992
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity
1985 StandoutNobel
Molecular Characterization of the Human β 3 -Adrenergic Receptor
1989 StandoutScience
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
1998 StandoutNobel
Dopamine Receptors: From Structure to Function
1998 Standout
5‐Substituted 1H‐Tetrazoles as Carboxylic Acid Isosteres: Medicinal Chemistry and Synthetic Methods
2003 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of A. Hilditch being referenced
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist
1994
SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors
1984
Presynaptic α‐adrenoceptors: do exogenous and neuronally released noradrenaline act at different sites?
1984
Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
1995
Peripheral dopamine receptor subtypes — a closer look
1985
Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle
1984
Subclassification of Peripheral Dopamine Receptors
1987
Effects of Dopamine Receptor Agonists and Antagonists at Peripheral Neuronal and Vascular Dopamine Receptors in the Anaesthetised Dog
1984
Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
1991
Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro
1985